Patents by Inventor The Board of Trustees of the Leland Stanford

The Board of Trustees of the Leland Stanford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130189580
    Abstract: Nanocarbon-based materials are provided in connection with various devices and methods of manufacturing. As consistent with one or more embodiments, an apparatus includes a nanocarbon structure having inorganic particles covalently bonded thereto. The resulting hybrid structure functions as a circuit node such as an electrode terminal. In various embodiments, the hybrid structure includes two or more electrodes, at least one of which including the nanocarbon structure with inorganic particles covalently bonded thereto.
    Type: Application
    Filed: February 15, 2013
    Publication date: July 25, 2013
    Applicant: The board of Trustees of the Leland Stanford Junior University
    Inventor: The board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130189254
    Abstract: Compositions and methods are provided for alleviating endometriosis, kidney disease, inflammatory disease and/or transplant rejection in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6.
    Type: Application
    Filed: December 14, 2012
    Publication date: July 25, 2013
    Applicants: Ruga Corporation, The Board of Trustees of the Leland Stanford Junior University
    Inventors: The Board of Trustees of the Leland Stanford Junior University, Ruga Corporation
  • Publication number: 20130184629
    Abstract: Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress.
    Type: Application
    Filed: March 7, 2013
    Publication date: July 18, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130185210
    Abstract: Among other things, the present disclosure describes an authentication system that leverage a mobile phone to improve the security of web logins and web payments on a personal computer. The described embodiments do not require special hardware beyond a cell phone with a camera. Using embodiments of the present invention, memorization of passwords is avoided and the login process is faster and less error-prone than with existing systems. In a payment system according to an embodiment, users do not need to let retailers keep their passwords because credit card information need to be manually input. In addition, the present invention allows users to conveniently take advantage of one-time use credit cards for additional security.
    Type: Application
    Filed: October 22, 2012
    Publication date: July 18, 2013
    Applicant: The Board of Trustees of the Leland Stanford, Junior, University
    Inventor: The Board of Trustees of the Leland Stanford, Junr
  • Publication number: 20130185097
    Abstract: Systems and methods for generating a medical score are disclosed. In some embodiments, an accurate medical score is generated within a relatively short period of time. The medical score can be derived from observational data and/or physiological time-series data collected from a subject. In some embodiments, a scoring system accesses the data, and at least a portion of the data is used in the calculation of the medical score. In certain embodiments, health care providers can use the medical score to make early predictions of complications in intensive care unit patients.
    Type: Application
    Filed: March 5, 2013
    Publication date: July 18, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130184535
    Abstract: A surgical access device facilitates access to a surgical site within a patient's body through an incision in the body. Surgical access devices can have a first retention member and a second retention member with a pliable membrane that extends between the first retention member and the second retention member. A retention member can include at least three linkages pivotably coupled to one another such that expanding the retention member causes at least some of the linkages to pivot relative to one another. The pliable membrane can be configured to expand the incision to facilitate access to the surgical site.
    Type: Application
    Filed: January 8, 2013
    Publication date: July 18, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130184518
    Abstract: Provided are methods for the determination of the viability of a mammalian embryo or a potential embryo generated from a mammalian oocyte, comprising applying a mechanical stimulus to the embryo or oocyte, detecting a temporal response of the embryo or oocyte to the mechanical stimulus, and deriving measurements for one or more parameters from the temporal response, the measurements being indicative of viability. Also provided are methods for selecting an embryo for transfer and methods for enhancing the viability of an embryo or oocyte.
    Type: Application
    Filed: January 11, 2013
    Publication date: July 18, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130178710
    Abstract: A surgical access system facilitates access to a surgical site within a patient's body through an incision in the body. Surgical access systems can have at least one retention member and a fluid transportation member configured to deliver fluid to a surgical site or to remove fluid from a surgical site. In some embodiments, a surgical access device irrigates a surgical site to reduce surgical site infections and removes fluid from the surgical site to increase a physician's visibility into the surgical site.
    Type: Application
    Filed: January 8, 2013
    Publication date: July 11, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130178709
    Abstract: Several methods to reduce surgical site infections include inserting a surgical access device into an incision, retracting tissue, and introducing fluid into the surgical access device such that the fluid exits the surgical access device and irrigates a surgical site. Other methods do not include introducing fluid into a surgical access device but include suctioning a fluid into the surgical access device and removing the fluid from the body.
    Type: Application
    Filed: January 8, 2013
    Publication date: July 11, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130172207
    Abstract: Disclosed are nanostructured gold films which may be produced by solution-phase depositions of gold ions onto a variety of surfaces. The resulting plasmonic gold films are used for enhanced spectroscopic-based immunoassays in multiplexed microarray format with detection mechanisms based on either surface-enhanced Raman scattering or near-infrared fluorescence enhancement. The preparation of the films and subsequent modifications of the gold film surfaces afford increased sensitivity for various microarrays. The films are discontinuous, forming gold “islands.” Sensitivity, size, shape, and density of the nanoscopic gold islands comprising the discontinuous nanostructured gold film are controlled to enhance the intensity of Raman scattering and fluorescence in the near-infrared, allowing for improved measurements in clinical diagnostic or biomedical research applications.
    Type: Application
    Filed: December 27, 2012
    Publication date: July 4, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130169855
    Abstract: Image data is processed to facilitate focusing and/or optical correction. According to an example embodiment of the present invention, an imaging arrangement collects light data corresponding to light passing through a particular focal plane. The light data is collected using an approach that facilitates the determination of the direction from which various portions of the light incident upon a portion of the focal plane emanate from. Using this directional information in connection with value of the light as detected by photosensors, an image represented by the light is selectively focused and/or corrected.
    Type: Application
    Filed: December 17, 2012
    Publication date: July 4, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130165944
    Abstract: Systems and methods are provided for removing an obstruction from a ureter using a catheter including a distal end sized for introduction into a ureter, an infusion lumen, and an aspiration lumen. An infusion tip is provided on the distal end that includes infusion ports communicating with the infusion lumen, and one or more aspiration ports communicating with the aspiration lumen. One or more sources of fluid and/or vacuum are connectable to the tubular member such that fluid is delivered into the infusion lumen and suction is delivered into the aspiration lumen. A controller is coupled to the source(s) to control delivery of fluid to generate a radially outward pressure against a wall of a ureter adjacent the infusion tip and to control suction through the aspiration port(s) to apply a suction force against a kidney stone located adjacent the infusion tip.
    Type: Application
    Filed: December 14, 2012
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Jr. University
    Inventor: The Board of Trustees of the Leland Stanford Jr. University
  • Publication number: 20130165463
    Abstract: The formation of scars at a wound site is reduced by contacting the wound site with an effective dose of an inhibitor of focal adhesion kinase (FAK) activity or expression. Blockade of FAK is sufficient to prevent mechanical and inflammatory stimuli from activating MCP-1 pathways. In addition to these chemokine-mediated mechanisms, inhibition of FAK may control fibrosis by blocking fibroblast collagen production. Pharmacologic blockade of FAK significantly reduces scar formation in vivo.
    Type: Application
    Filed: December 5, 2012
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130164283
    Abstract: Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell killing are provided. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. Preferably, the cell surface antigen is associated with the cytoskeleton of the cell. A preferred polyvalent agent is an IgM, and enhanced cell wounding and killing can be provided by the addition of a crosslinking agent. At sublethal concentrations in vivo, the cell wounding antibodies permeabilize cells and dramatically enhance response to chemotherapeutic agents, even in patients refractory to the chemotherapeutic agents.
    Type: Application
    Filed: February 19, 2013
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130165974
    Abstract: Devices, systems and methods for dynamically stabilizing the spine are provided. The devices include an expandable spacer having an undeployed configuration and a deployed configuration, wherein the spacer has axial and radial dimensions for positioning between the spinous processes of adjacent vertebrae. The systems include one or more spacers and a mechanical actuation means for delivering and deploying the spacer. The methods involve the implantation of one or more spacers within the interspinous space.
    Type: Application
    Filed: February 25, 2013
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130165745
    Abstract: Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.
    Type: Application
    Filed: February 1, 2013
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130162795
    Abstract: Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.
    Type: Application
    Filed: February 1, 2013
    Publication date: June 27, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130148897
    Abstract: The disclosure relates to a method comprising receiving an image; filtering the image by a first filter to obtain a set of first filtered values and by a second filter to obtain a set of second filtered values. The first filtered values are stored. An algorithm is applied to the set of first filtered values and the set of second filtered values to obtain a set of results. At least one local maximum, local minimum or both of the results are searched to determine a location of an interest point. A descriptor is determined for a detected interest point on the basis of the stored one or more first filtered values. The disclosure also relates to an apparatus and a storage medium.
    Type: Application
    Filed: November 20, 2012
    Publication date: June 13, 2013
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Nokia Corporation
    Inventors: Nokia Corporation, The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130150399
    Abstract: Compounds that are inhibitors of the unfolded protein response and endonuclease IRE1 are provided, together with compositions comprising such compounds, and methods for their use in the treatment of various disorders, such as cancer, autoimmune disorders, and diabetes. Also provided are packaged pharmaceuticals comprising these compositions. The compositions may be administered in combination with another therapeutic agent.
    Type: Application
    Filed: February 11, 2013
    Publication date: June 13, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventor: The Board of Trustees of the Leland Stanford Junior University
  • Publication number: 20130149860
    Abstract: A method of fabricating single-crystalline metal silicide nanowires for anti-reflective electrodes for photovoltaics is provided that includes exposing a surface of a metal foil to oxygen or hydrogen at an elevated temperature, and growing metal silicide nanowires on the metal foil surface by flowing a silane gas mixture over the metal foil surface at the elevated temperature, where spontaneous growth of the metal silicide nanowires occur on the metal foil surface, where the metal silicide nanowires are post treated for use as an electrode in a photovoltaic cell or used directly as the electrode in the photovoltaic cell.
    Type: Application
    Filed: December 10, 2012
    Publication date: June 13, 2013
    Applicants: Honda Motor Co., LTD, The Board of Trustees of the Leland Stanford Junior University
    Inventors: The Board of Trustees of the Leland Stanford Junior University, Honda Motor Company., LTD